Artery is presenting a poster and short video at CTAD 2020, titled "CS6253 ABCA1 agonist treatment in cynomolgus monkeys reduces cerebrospinal fluid concentrations of Aβ42, Aβ40, APP and AP2B1 in dose-response manner." The authors are J.O.
2020-11-04 · Artery Therapeutics, Inc. · original arterytx.com ↗
Artery is presenting a poster and short video at CTAD 2020, titled "CS6253 ABCA1 agonist treatment in cynomolgus monkeys reduces cerebrospinal fluid concentrations of Aβ42, Aβ40, APP and AP2B1 in dose-response manner." The authors are J.O. Johansson 1, H.N. Yassine 2, D.M. Michaelson 3, J.E.G. Johansson 4, H. Zetterberg 5, B. Winblad 6, J.L. Cummings 7 1Artery Therapeutics, Inc. - San Ramon, Ca (United States), 2Usc - Los Angeles (United States), 3Tel Aviv University - Tel Aviv (Israel), 4Artery Therapeutics, Inc. - San Ramon (United States), 5U Of Gothenburg - Gothenburg (Sweden), 6Karolinska Institutet - Stockholm (Sweden), 7Unlv - Las Vegas (United States).
The release as fetched from its publisher. arterytx.com ↗